Researchers have discovered that a hormone, fibroblast growth factor 21 (FGF21), is extremely elevated in mice with liver disease that […]
Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study: Trial reveals 43 percent complete response rate for triple therapy
A triple therapy combining two immune checkpoint inhibitors (ICPIs) with the standard-of-care chemotherapy, a hypomethylating agent called azacitidine, has shown […]
Experimental drug more effective in treating rare kidney disease
An experimental drug is more than twice as effective as the standard treatment at reducing a key measure of severity […]
Cluster of factors could help predict C. diff: Study finds evidence that could lead to prevention of life-threatening infections
A cluster of factors may help predict which patients are likely to develop Clostridioides difficile, a potentially life-threatening disease commonly […]
Testosterone replacement therapy may slow the progression of COPD
Researchers from The University of Texas Medical Branch at Galveston found that testosterone replacement therapy may slow disease progression of […]
Anticancer drug offers potential alternative to transplant for patients with liver failure
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for […]
New targets found to reduce blood vessel damage in diabetes
In diabetes, both the tightly woven endothelial cells that line our blood vessels and the powerhouses that drive those cells […]